AbbVie and Allergan are closer to completing the $63 billion combination of the two companies after entering into a consent decree agreement with the Federal Trade Commission that commits them to a previously announced divestiture of products ahead of the merger.

Waltham, Mass.-based AMAG Pharmaceuticals will secure $530 million in cash as the company divests Cord Blood Registry to GI Partners, a private equity investment firm.

Teva Pharmaceutical Industries Ltd. is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital Partners, the Fly reported, citing Bloomberg.